Literature DB >> 20066663

Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes.

Emiko Fire1, Stefano V Gullá, Robert A Grant, Amy E Keating.   

Abstract

Mcl-1 is an antiapoptotic Bcl-2-family protein that protects cells against death. Structures of Mcl-1, and of other anti-apoptotic Bcl-2 proteins, reveal a surface groove into which the alpha-helical BH3 regions of certain proapoptotic proteins can bind. Despite high overall structural conservation, differences in this groove afford binding specificity that is important for the mechanism of Bcl-2 family function. We report the crystal structure of human Mcl-1 bound to a BH3 peptide derived from human Bim and the structures for three complexes that accommodate large physicochemical changes at conserved Bim sites. The mutations had surprisingly modest effects on complex stability, and the structures show that Mcl-1 can undergo small changes to accommodate the mutant ligands. For example, a shift in a leucine side chain fills a hole left by an isoleucine-to-alanine mutation at the first hydrophobic buried position of Bim BH3. Larger changes are also observed, with shifting of helix alpha3 accommodating an isoleucine-to-tyrosine mutation at this same position. We surveyed the variation in available Mcl-1 and Bcl-x(L) structures and observed moderate flexibility that is likely critical for facilitating interactions of diverse BH3-only proteins with Mcl-1. With the antiapoptotic Bcl-2 family members attracting significant attention as therapeutic targets, these structures contribute to our growing understanding of how specificity is achieved and can help to guide the design of novel inhibitors that target Mcl-1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20066663      PMCID: PMC2866276          DOI: 10.1002/pro.329

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  43 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

Authors:  A M Petros; D G Nettesheim; Y Wang; E T Olejniczak; R P Meadows; J Mack; K Swift; E D Matayoshi; H Zhang; C B Thompson; S W Fesik
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

3.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

4.  Substructure solution with SHELXD.

Authors:  Thomas R Schneider; George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-09-28

Review 5.  The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions.

Authors:  Christoph Borner
Journal:  Mol Immunol       Date:  2003-01       Impact factor: 4.407

6.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

7.  Likelihood-enhanced fast rotation functions.

Authors:  Laurent C Storoni; Airlie J McCoy; Randy J Read
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-02-25

8.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

Authors:  Anthony Letai; Michael C Bassik; Loren D Walensky; Mia D Sorcinelli; Solly Weiler; Stanley J Korsmeyer
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

9.  Solution structure of the antiapoptotic protein bcl-2.

Authors:  A M Petros; A Medek; D G Nettesheim; D H Kim; H S Yoon; K Swift; E D Matayoshi; T Oltersdorf; S W Fesik
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

10.  The structure of a Bcl-xL/Bim fragment complex: implications for Bim function.

Authors:  Xinqi Liu; Shaodong Dai; Yanan Zhu; Philippa Marrack; John W Kappler
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

View more
  37 in total

1.  Heterodimerization of BAK and MCL-1 activated by detergent micelles.

Authors:  Qian Liu; Kalle Gehring
Journal:  J Biol Chem       Date:  2010-10-29       Impact factor: 5.157

Review 2.  Protein binding specificity versus promiscuity.

Authors:  Gideon Schreiber; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2010-11-09       Impact factor: 6.809

Review 3.  Designing specific protein-protein interactions using computation, experimental library screening, or integrated methods.

Authors:  T Scott Chen; Amy E Keating
Journal:  Protein Sci       Date:  2012-06-08       Impact factor: 6.725

4.  Insights into the structural stability of Bax from molecular dynamics simulations at high temperatures.

Authors:  Jorge Luis Rosas-Trigueros; José Correa-Basurto; Claudia Guadalupe Benítez-Cardoza; Absalom Zamorano-Carrillo
Journal:  Protein Sci       Date:  2011-11-01       Impact factor: 6.725

Review 5.  Progress in targeting the BCL-2 family of proteins.

Authors:  Thomas P Garner; Andrea Lopez; Denis E Reyna; Adam Z Spitz; Evripidis Gavathiotis
Journal:  Curr Opin Chem Biol       Date:  2017-08-17       Impact factor: 8.822

6.  Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins.

Authors:  Glenna Wink Foight; Amy E Keating
Journal:  J Mol Biol       Date:  2015-05-23       Impact factor: 5.469

7.  Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.

Authors:  Chunwei Cheng; Maria E Balasis; Yan Liu; Thomas P Garner; Rongshi Li; Kenyon G Daniel; Jerry Li; Yong Qin; Evripidis Gavathiotis; Said M Sebti
Journal:  Eur J Med Chem       Date:  2014-11-20       Impact factor: 6.514

Review 8.  Mechanisms of action of Bcl-2 family proteins.

Authors:  Aisha Shamas-Din; Justin Kale; Brian Leber; David W Andrews
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

9.  Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design.

Authors:  Anders Friberg; Dominico Vigil; Bin Zhao; R Nathan Daniels; Jason P Burke; Pedro M Garcia-Barrantes; DeMarco Camper; Brian A Chauder; Taekyu Lee; Edward T Olejniczak; Stephen W Fesik
Journal:  J Med Chem       Date:  2012-12-17       Impact factor: 7.446

Review 10.  Intrinsically disordered proteins in bcl-2 regulated apoptosis.

Authors:  Gilles J P Rautureau; Catherine L Day; Mark G Hinds
Journal:  Int J Mol Sci       Date:  2010-04-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.